NYDailyNews.com

WASHINGTON – The widely used preservative formaldehyde and the coffee-cup component styrene were added to a list of known and suspected carcinogens by the feds. Formaldehyde, linked to leukemia and a rare type of nasal cancer, is “known to be a human carcinogen,” according to a report by the National Institutes of Health. Styrene, often used in food containers, is categorized by researchers as “reasonably anticipated” to be cancer-causing. They were among eight new agents listed as carcinogens, bringing the total to 240. The cancer-causing risk from formaldehyde and styrene comes from the products’ widespread use in industrial applications and less from their presence in consumer products, officials said.

Read the Full Story Here: http://www.nydailynews.com/lifestyle/health/2011/06/12/2011-06-12_two_main_components_of_coffee_cups_and_carry_out_containers_identified_as_cancer.html?r=lifestyle/health

We Lost the War on Cancer – Review of Alternative Cancer Therapies

eBook
Retail : $9⁹⁹
Now : $5⁹⁹

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.